Differences between Keratoacanthoma and Squamous Cell Carcinoma Using TGF-α

被引:0
作者
Cabrijan, Leo [1 ]
Lipozencic, Jasna [2 ]
Batinac, Tanja [1 ]
Lenkovic, Maja [1 ]
Zgombic, Zrinka Stanic [1 ]
机构
[1] Univ Rijeka, Rijeka Univ Hosp Ctr, Dept Dermatovenereol, Rijeka 51000, Croatia
[2] Univ Zagreb, Zagreb Univ Hosp Ctr, Dept Dermatol & Venereol, Zagreb 41000, Croatia
关键词
keratoacanthoma; squamous cell carcinoma; TGF-alpha; GROWTH-FACTOR-ALPHA; NECK-CANCER; DISTINGUISH KERATOACANTHOMAS; HUMAN KERATINOCYTES; EXPRESSION; HEAD; APOPTOSIS; MARKERS; EGFR;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Squamous cell carcinoma (SCC) and keratoacanthoma (KA) are skin neoplasms of epithelial origin. In contrast to clearly malignant skin neoplasm SCC, KA is an unusual cutaneous neoplasm with a tendency to regression. The distinction between these two neoplasms, on histological grounds only, is still a challenge. In order to investigate further and to assess the possible differences in transforming growth factor-alpha (TGF-alpha) expression between SCC and KA, 40 of skin tumor specimens, 20 cases of each SCC and KA were analyzed immunohystochemicaly. We have found a significant difference in staining patterns between KA and SCC. In KAs we have detected TGF-alpha staining mainly diffusely (90% of cases) and without peripheral staining of cells in 1-2 layers (60% of cases). Contrary, there was a mostly patchy staining (55% of cases) with peripheral staining of cells in 1-2 layers (100% of cases) in SCCs. Generally, differentiation between KA and SCC can be based on clinical and histological ground, but the distinction between these two skin tumors could sometimes be difficult. We have shown that these skin neoplasms could be differentiated based on staining patterns of TGF-alpha expression, thus this method could aid in differentiation between these two closely related entities in clinical practice.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [31] The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma
    Vasiljevic, Natasa
    Andersson, Kristin
    Bjelkenkrantz, Kaj
    Kjellstrom, Christer
    Mansson, Henrik
    Nilsson, Elise
    Landberg, Goran
    Dillner, Joakim
    Forslund, Ola
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (10) : 2361 - 2366
  • [32] To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma
    Poole, Mackenzie
    Schwartz, Robert A.
    Lambert, W. Clark
    Alhatem, Albert
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (04) : 903 - 915
  • [33] Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma
    Leblebici, Cem
    Pasaoglu, Esra
    Kelten, Canan
    Darakci, Seher
    Dursun, Nevra
    [J]. ONCOLOGY LETTERS, 2017, 13 (04) : 2539 - 2548
  • [34] P53 EXPRESSION IRE PSEUDOEPITHELIOMATOUS HYPERPLASIA, KERATOACANTHOMA, AND SQUAMOUS-CELL CARCINOMA OF SKIN
    LEE, YS
    TEH, M
    [J]. CANCER, 1994, 73 (09) : 2317 - 2323
  • [35] Differences Between Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Are Adenocarcinoma and Squamous Cell Carcinoma Prognostically Equal?
    Kawase, Akikazu
    Yoshida, Junji
    Ishii, Genichiro
    Nakao, Masayuki
    Aokage, Keiju
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (03) : 189 - 195
  • [36] Esophageal Carcinoma: Prognostic Differences between Squamous Cell Carcinoma And Adenocarcinoma
    Christophe Mariette
    Laetitia Finzi
    Guillaume Piessen
    Isabelle Van Seuningen
    Jean Pierre Triboulet
    [J]. World Journal of Surgery, 2005, 29 : 39 - 45
  • [37] Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma
    Scola, N.
    Segert, H. M.
    Stuecker, M.
    Altmeyer, P.
    Gambichler, T.
    Kreuter, A.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (02) : 216 - 218
  • [38] TGF-α, c-erbB-2 expression and neoangiogenesis in vulvar squamous cell carcinoma
    Hantschmann, P
    Jeschke, U
    Friese, K
    [J]. ANTICANCER RESEARCH, 2005, 25 (3A) : 1731 - 1737
  • [39] TGF-β receptor I conditional knockout mice develop spontaneous squamous cell carcinoma
    Honjo, Yasuyuki
    Bian, Yansong
    Kawakami, Koji
    Molinolo, Alfredo
    Longenecker, Glenn
    Boppana, Ramanamurthy
    Larsson, Jonas
    Karlsson, Stefan
    Gutkind, J. Silvio
    Puri, Raj K.
    Kulkarni, Ashok B.
    [J]. CELL CYCLE, 2007, 6 (11) : 1360 - 1366
  • [40] The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma
    Mukunyadzi, P
    Sanderson, RD
    Fan, CY
    Smoller, BR
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 45 - 49